Which is more profitable, Amgen or Bristol-Myers Squibb?

Amgen keeps more of every sale as profit.

Which grows faster, Amgen or Bristol-Myers Squibb?

Amgen grew its sales faster in recent years.

Which is cheaper, Amgen or Bristol-Myers Squibb?

Bristol-Myers Squibb costs less for each unit of yearly profit (lower P/E).

Which has less debt, Amgen or Bristol-Myers Squibb?

Bristol-Myers Squibb would need fewer years of earnings to pay off its debt.

AmgenAMGNvs

Bristol-Myers SquibbBMY

Amgen vs Bristol-Myers Squibb stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Amgen is more profitable and grows faster. Bristol-Myers Squibb is cheaper for its profits and has less debt.

Side by side

	Amgen	Bristol-Myers Squibb
	$252 billion	$130 billion
	21.0%	14.6%
	+7.6%	+2.5%
	32.7×	18.4×
	2.7 years	2.4 years
	15.0%	13.9%
	2.9%	4.4%

Open Amgen Open Bristol-Myers Squibb

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Amgen vs Gilead Sciences · Amgen vs Intuitive Surgical · Amgen vs Johnson & Johnson · Amgen vs Eli Lilly · Bristol-Myers Squibb vs Intuitive Surgical · Bristol-Myers Squibb vs Johnson & Johnson · Bristol-Myers Squibb vs Eli Lilly · Bristol-Myers Squibb vs McKesson